A new combination of drugs, Imdelltra and Imfinzi, has demonstrated a 58% reduction in the risk of death and an extension of median survival by over eight months for patients with small cell lung cancer, compared to standard treatment. #cancerpulmonar #imunoterapie #tratamentnovel (translated)
